Thursday, December 19

Tag: Wegovy

U.S. poison centers see spike in calls over weight-loss drugs
16Dec By adminNo Comments
Health

U.S. poison centers see spike in calls over weight-loss drugs

U.S. poison centers see spike in calls over weight-loss drugs - CBS News Watch CBS News America's Poison Centers, a group that represents poison control centers across the U.S., reported a major spike in calls this year related to semaglutide, the main ingredient in weight loss drugs such as Ozempic and Wegovy. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On
Read More
WeightWatchers launches program for users of Ozempic and other weight-loss drugs
15Dec By adminNo Comments
Money

WeightWatchers launches program for users of Ozempic and other weight-loss drugs

WeightWatchers has started a new chapter as the 60-year company looks to tap the fast-growing market for people using prescription weight-loss drugs.The diet company this week launched WeightWatchers GLP-1, a subscription program focused on the health and nutrition needs of patients using Ozempic and Wegovy, two brands of semaglutide, a diabetes drug that has exploded in popularity for its effectiveness in helping people lose weight. With its new membership offering, WeightWatchers is hoping to stay relevant in a rapidly changing industry. Widespread use of Ozempic and Wegovy has upended the diet industry and even changed consumer eating habits. An estimated 24 million people, or 7% of the U.S. population, could be using the drugs by 2035, according to a report by Morgan Stanley Research....
Read More
Black patients have less access to anti-obesity drugs, data shows
19Nov By adminNo Comments
Health

Black patients have less access to anti-obesity drugs, data shows

Black patients have less access to anti-obesity drugs, data shows Black patients have less access to anti-obesity drugs, data shows 01:01 BOSTON -  The new anti-obesity and diabetes drugs may not be going to the patients who need them the most.  Once again, we're seeing health disparities when it comes to the distribution of these drugs.The demand for drugs like Ozempic and Wegovy has skyrocketed in recent months but not everyone has equal a...
Read More
Weight loss drug Wegovy cut risk of serious heart problems by 20%, study finds
13Nov By adminNo Comments
Health

Weight loss drug Wegovy cut risk of serious heart problems by 20%, study finds

Weight loss drug Wegovy cut risk of serious heart problems by 20%, study finds - CBS News Watch CBS News A new study published in the The New England Journal of Medicine by the maker of the popular weight loss drug Wegovy finds the medication could lower the risk of serious and even deadly heart problems by 20%. CBS News chief medical correspondent Dr. Jon LaPook joins "CBS Mornings" to discuss. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On
Read More
FDA investigating reports of hospitalizations after fake Ozempic
12Nov By adminNo Comments
Health

FDA investigating reports of hospitalizations after fake Ozempic

At least three Americans have been reported hospitalized after using suspected counterfeits of semaglutide drugs, which include Novo Nordisk's diabetes medication Ozempic, according to records released by the Food and Drug Administration. Ozempic and Wegovy, another semaglutide medication from Novo Nordisk, have been in short supply for months amid booming sales for their use in weight loss. The hospitalizations are among 42 reports to the FDA's Adverse Event Reporting System that mention use of counterfeit semaglutide from around the world. The agency last updated its database at the end of last month to include reports tallied through the end of September. Of the reports, 28 are classified as "serious" with outcomes that also include deaths. Only a po...
Read More
Weight loss drugs Ozempic, Wegovy linked to severe stomach problems, study finds
7Oct By adminNo Comments
Health

Weight loss drugs Ozempic, Wegovy linked to severe stomach problems, study finds

Weight loss drugs Ozempic, Wegovy linked to severe stomach problems, study finds - CBS News Watch CBS News Popular weight loss drugs Ozempic and Wegovy have been linked to an increased risk of severe stomach problems, including pancreatitis and stomach paralysis. CBS News' Elaine Quijano reports on the new JAMA study. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On
Read More
FDA updates Ozempic label with potential blocked intestines side effect, also reported with Wegovy and Mounjaro
28Sep By adminNo Comments
Health

FDA updates Ozempic label with potential blocked intestines side effect, also reported with Wegovy and Mounjaro

The label for the diabetes drug Ozempic — which has become popular for weight loss — now acknowledges reports of blocked intestines following use of the medication. The change comes after the Food and Drug Administration greenlighted a series of updates from drugmaker Novo Nordisk for its product. Ozempic now joins other products in this booming class of so-called GLP-1 agonist medications which acknowledge increased reports of what doctos call ileus, or a blockage in the intestines. Weight loss drug Wegovy, which is also an injection of semaglutide manufactured by Novo Nordisk, acknowledges reports of ileus on its label as well, as does Mounjaro, a diabetes medication from Eli Lilly. However, the FDA stopped short of directly blaming the potentially li...
Read More